Roni Nitecki Wilke

19PUBLICATIONS
87CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyCancer geneticsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 01, 2025
Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities.

Anne Knisely, Yibo Dai, Graham L Barlow

|Nov 04, 2024
Oncologic outcomes of incidental serous tubal intraepithelial carcinoma and associated high-grade serous carcinoma in high-risk patients undergoing risk-reducing surgery.

Eliane Aoun, Barrett Lawson, Chika Awujo

|Oct 16, 2024
The association of the chemotherapy response score and homologous recombination deficiency in patients undergoing interval tumor reductive surgery following neoadjuvant chemotherapy.

Roni Nitecki Wilke, Jinsong Liu, Shannon Neville Westin

|Jul 31, 2024
Racial and sociodemographic disparities in the use of targeted therapies in advanced ovarian cancer patients with Medicare.

Anne Knisely, Chi-Fang Wu, Alexa Kanbergs

|Jun 26, 2024
Adjuvant external beam radiotherapy combined with brachytherapy for intermediate-risk cervical cancer.

Nuria Agusti, David Viveros-Carreño, Alexander Melamed

|Nov 01, 2023
Experiences of Family Communication and Cascade Genetic Testing for Hereditary Cancer in Medically Underserved Populations-A Qualitative Study.

Erica M Bednar, J Alejandro Rauh-Hain, Jose J Garcia

Pageof 4